| Filed | Description | |
|---|---|---|
| 9/26/25 | 1.01 Material Agreement | → |
| 8/7/25 | 1.01 Material Agreement | → |
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1 (GLP-1).